ClinicalTrials.Veeva

Menu

Outcome Predictors of Trachea-esophageal Fistula

A

Assiut University

Status

Not yet enrolling

Conditions

Tracheo Esophageal Fistula

Treatments

Procedure: Tracheoesophageal fistula repair

Study type

Observational

Funder types

Other

Identifiers

NCT05847101
trachea-esophageal fistula

Details and patient eligibility

About

In the present study, the investigator aim to evaluate the prevalence, factors affecting outcome and the outcome of neonates with tracheoesophageal fistula.

Full description

Tracheoesophageal fistula is a connection between the esophagus and the trachea.

Tracheoesophageal fistula (TEF) represents one of the most common congenital anomalies seen in infants, Infants with TEF classically present with respiratory distress, feeding difficulties, choking, and risk for aspiration. TEF is most commonly associated with other congenital anomalies, particularly cardiac defects. Esophageal atresia (EA) is a related congenital malformation with a similar presentation to TEF and can occur with or without the presence of a fistula.

Although the events leading to separation of the primitive trachea and esophagus are not completely understood, the most commonly accepted hypothesis is that a defect in the lateral septation of the foregut into the trachea and esophagus causes TEF and EA.

The trachea and esophagus develop from a common primitive foregut, and at approximately 4 weeks of gestation, the developing respiratory and gastrointestinal tracts are separated by epithelial ridges. The foregut divides into a ventral respiratory tract and a dorsal esophageal tract; the fistula tract is thought to derive from an embryonic lung bud that fails to undergo branching. These defects of mesenchymal proliferation are thought to lead to TEF formation.

The incidence of TEF is approximately 1 in 3500 births. EA and TEF are classified according to their anatomic configuration.

Enrollment

100 estimated patients

Sex

All

Ages

Under 28 days old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients diagnosed with tracheoesophageal fistula are/below the age of 28 days.

Exclusion criteria

  • Patients above the age of 28 days.
  • Patients diagnosed with other diseases.
  • Patients with acquired tracheoesophageal fistula.

Trial contacts and locations

0

Loading...

Central trial contact

Assem Abd Elrazek, doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems